A systematic review of interleukin-2-based immunotherapies in clinical trials for cancer and autoimmune diseases https://www.medrxiv.org/content/10.1101/2022.12.02.22283042
CleverLibre Social is an inclusive social instance for open discussion, learning, and community. All cultures welcome. Hate speech and harassment strictly forbidden.